{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:50:19Z","timestamp":1792759819383,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10840-020-00705-1","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T19:02:47Z","timestamp":1581793367000},"page":"233-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Outcome of implantable cardioverter defibrillator in cardiac sarcoidosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-2378","authenticated-orcid":false,"given":"Ahmad","family":"Halawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit K.","family":"Turagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred M.","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henok G.","family":"Woldu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"issue":"1","key":"705_CR1","first-page":"50","volume":"6","author":"E Hulten","year":"2016","unstructured":"Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016;6(1):50\u201363.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"3","key":"705_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/europace\/eus406","volume":"15","author":"PM Heck","year":"2013","unstructured":"Heck PM, Roberts PR. The role of implantable cardiac defibrillators in cardiac sarcoidosis: saviour or sinner? Europace. 2013;15(3):309\u201310.","journal-title":"Europace."},{"issue":"10","key":"705_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/clc.22430","volume":"38","author":"DG Rosenthal","year":"2015","unstructured":"Rosenthal DG, Bravo PE, Patton KK, Goldberger ZD. Management of Arrhythmias in cardiac Sarcoidosis. Clin Cardiol. 2015;38(10):635\u201340.","journal-title":"Clin Cardiol"},{"issue":"10","key":"705_CR4","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","volume":"4","author":"K Banba","year":"2007","unstructured":"Banba K, Kusano KF, Nakamura K, Morita H, Ogawa A, Ohtsuka F, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm. 2007;4(10):1292\u20139.","journal-title":"Heart Rhythm"},{"issue":"6","key":"705_CR5","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","volume":"9","author":"BP Betensky","year":"2012","unstructured":"Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm. 2012 Jun;9(6):884\u201391.","journal-title":"Heart Rhythm."},{"issue":"9","key":"705_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","volume":"88","author":"Y Yazaki","year":"2001","unstructured":"Yazaki Y, Isobe M, Hiroe M, Morimoto SI, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88(9):1006\u201310.","journal-title":"Am J Cardiol"},{"issue":"12","key":"705_CR7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ejhf.1319","volume":"20","author":"LA Fussner","year":"2018","unstructured":"Fussner LA, Karlstedt E, Hodge DO, Fine NM, Kalra S, Carmona EM, et al. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres. Eur J Heart Fail. 2018;20(12):1713\u201320.","journal-title":"Eur J Heart Fail"},{"key":"705_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijcard.2016.11.041","volume":"228","author":"A Louise","year":"2017","unstructured":"Louise A, Lin Y-J, Chen Y-Y, Chung F-P, Chang S-L, Lo L-W, et al. Increased risk of ventricular tachycardia in patients with sarcoidosis during the very long term follow-up. Int J Cardiol. 2017;228:68\u201373.","journal-title":"Int J Cardiol"},{"issue":"1897","key":"705_CR9","first-page":"5593","volume":"1","author":"A Salama","year":"2018","unstructured":"Salama A, Abdullah A, Wahab A, Eigbire G, Hoefen R, Alweis R. Cardiac sarcoidosis and ventricular arrhythmias. A rare association of a rare disease. A retrospective cohort study from the National Inpatient Sample and current evidence for management. Cardiol J. 2018;1(1897):5593.","journal-title":"Cardiol J"},{"issue":"13","key":"705_CR10","first-page":"e210","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Circulation. 2018;138(13):e210\u201371.","journal-title":"Circulation."},{"issue":"7","key":"705_CR11","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Hear Rhythm. 2014;11(7):1305\u201323.","journal-title":"Hear Rhythm."},{"issue":"9","key":"705_CR12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","volume":"23","author":"JL Schuller","year":"2012","unstructured":"Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2012;23(9):925\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"705_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/jce.12302","volume":"25","author":"A Mohsen","year":"2014","unstructured":"Mohsen A, Jimenez A, Hood RE, Dickfeld T, Saliaris A, Shorofsky S, et al. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol. 2014;25(2):171\u20136.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"705_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ijcard.2017.04.044","volume":"240","author":"Y Takaya","year":"2017","unstructured":"Takaya Y, Kusano K, Nishii N, Nakamura K, Ito H. Early and frequent defibrillator discharge in patients with cardiac sarcoidosis compared with patients with idiopathic dilated cardiomyopathy. Int J Cardiol. 2017;240:302\u20136.","journal-title":"Int J Cardiol"},{"issue":"1","key":"705_CR15","first-page":"70","volume":"32","author":"D Bandyopadhyay","year":"2015","unstructured":"Bandyopadhyay D, Sahoo D, Zein J, Brunken RC, Tchou PJ, Culver DA. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- a propensity matched analysis. Sarcoidosis Vasc Diffus Lung Dis. 2015;32(1):70\u20139.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"issue":"2","key":"705_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.amjcard.2005.03.059","volume":"96","author":"A Aizer","year":"2005","unstructured":"Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol. 2005;96(2):276\u201382.","journal-title":"Am J Cardiol"},{"issue":"3","key":"705_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/europace\/eus316","volume":"15","author":"J Kron","year":"2013","unstructured":"Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2013;15(3):347\u201354.","journal-title":"Europace."},{"issue":"1","key":"705_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","volume":"4","author":"D Mehta","year":"2011","unstructured":"Mehta D, Mori N, Goldbarg SH, Lubitz S, Wisnivesky JP, Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis role of programmed ventricular stimulation. Circ Arrhythmia Electrophysiol. 2011;4(1):43\u20138.","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"705_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1536\/ihj.47.363","volume":"47","author":"H Watanabe","year":"2006","unstructured":"Watanabe H, Chinushi M, Izumi D, Sato A, Okada S, Okamura K, et al. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator. Int Heart J. 2006;47:363\u201370.","journal-title":"Int Heart J"},{"key":"705_CR20","doi-asserted-by":"publisher","unstructured":"Nakano M, Kondo Y, Nakano M, Miyazawa K, Hayashi T KY. Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator-primary versus secondary prevention. In: Sudden cardiac death and implantable defibrillator [internet]. EP Europace, volume 19, issue suppl_3, 1 June 2017, pages iii301; 2017. p. Pages iii301. Available from: https:\/\/doi.org\/10.1093\/ehjci\/eux158.105.","DOI":"10.1093\/ehjci\/eux158.105"},{"key":"705_CR21","unstructured":"Higgins JPT GS. Cochrane handbookfor systematic reviews of interventions version 5.1.0 [Internet]. The Cochrane Collaboration. 2011. Available from: www.handbook.cochran.org"},{"issue":"7414","key":"705_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ Br Med J. 2003;327(7414):557\u201360.","journal-title":"BMJ Br Med J"},{"key":"705_CR23","first-page":"1","volume":"3","author":"GA Wells","year":"2013","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hosp Res Inst. 2013;3:1\u20134.","journal-title":"Ottawa Hosp Res Inst"},{"key":"705_CR24","doi-asserted-by":"crossref","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw [Internet]. 2010;36(3). Available from: https:\/\/www.jstatsoft.org\/v036\/i03","DOI":"10.18637\/jss.v036.i03"},{"issue":"9","key":"705_CR25","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jacep.2018.05.007","volume":"4","author":"M Vaseghi","year":"2018","unstructured":"Vaseghi M, Hu TY, Tung R, Vergara P, Frankel DS, Di Biase L, et al. Outcomes of catheter ablation of ventricular tachycardia based on etiology in nonischemic heart disease. JACC Clin Electrophysiol. 2018;4(9):1141\u201350.","journal-title":"JACC Clin Electrophysiol"},{"issue":"13","key":"705_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","volume":"375","author":"L K\u00f8ber","year":"2016","unstructured":"K\u00f8ber L, Thune JJ, Nielsen JC, Haarbo J, Videb\u00e6k L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221\u201330.","journal-title":"N Engl J Med"},{"issue":"3","key":"705_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225\u201337.","journal-title":"N Engl J Med"},{"issue":"4","key":"705_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","volume":"6","author":"S Greulich","year":"2013","unstructured":"Greulich S, Deluigi CC, Gloekler S, Wahl A, Z\u00fcrn C, Kramer U, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501\u201311.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"705_CR29","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/eurheartj\/ehp592","volume":"31","author":"G Lin","year":"2010","unstructured":"Lin G, Dispenzieri A, Brady PA. Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death. Eur Heart J. 2010;31(12):1538.","journal-title":"Eur Heart J"},{"issue":"2","key":"705_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","volume":"16","author":"K Yodogawa","year":"2011","unstructured":"Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac Sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16(2):140\u20137.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"2","key":"705_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1086\/518889","volume":"45","author":"MR Sohail","year":"2007","unstructured":"Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007;45(2):166\u201373.","journal-title":"Clin Infect Dis"},{"issue":"131","key":"705_CR32","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"17","author":"R Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, Vihinen T. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;17(131):624\u201332.","journal-title":"Circulation."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00705-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-020-00705-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00705-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T09:52:16Z","timestamp":1613296336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-020-00705-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["705"],"URL":"https:\/\/doi.org\/10.1007\/s10840-020-00705-1","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,15]]},"assertion":[{"value":"28 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}